Semi-Solid Dosage Contract Manufacturing Market, By Product, By Application, By Type, By Company Size, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Semi-Solid Dosage Contract Manufacturing Market size was valued at US$ 20,980.2 Million in 2025, expanding at a CAGR of 12.4% from 2026 to 2033.

The semi-solid dosage contract manufacturing market involves outsourcing activities, including formulation development, process refinement, scale-up, GMP production, filling, packaging, analytical tests, and regulatory support of creams, gels, ointments, pastes, lotions, and other formulations. Emulsifying, homogenizing, dispersing, controlling rheology, deairing, microbiological, and filling processes are usually involved in the production process, while the sterile method is used when necessary.

The dermatology category accounts for the largest share of the market, while areas such as gynecology, eye care, hormone-based drugs, and other topical treatments typically involve higher complexities in formulation and production. The FDA reports 689 ANDA approvals in 2025, showcasing the market's continuous interest in generic drug manufacturing. Overall, the market's focus is on the formulation capabilities, regulatory support, scalability of processes, and other commercial aspects offered by contract manufacturers.

Semi-Solid Dosage Contract Manufacturing Market- Market Dynamics

Regulatory Complexity Strengthens Demand for Specialized Manufacturing Expertise

Regulatory requirements are driving expertise in the field to a level that makes formulation expertise a key criterion for outsourcing decisions. The physical properties of semi-solid products, along with characteristics such as consistency, particle size, distribution, content uniformity, physical and microbiological stability, and the release of the active pharmaceutical ingredient, make these dosage forms particularly challenging in terms of technology transfer. Sponsors are now looking to contract development manufacturing organizations (CDMOs) that can manage formulation development, analytical assessment, validation, clinical-batch production, commercial-scale manufacturing, and regulatory filings by applying integrated approaches. With 250 tentative approvals of abbreviated new drug applications (ANDAs) in 2025, the FDA has seen a significant rise in generic drug development. Thus, CDMOs are now prioritizing the capability to handle the most complex processes and offer end-to-end services that leverage advanced development and analytical laboratories, regulatory expertise, and extensive experience in bringing generic and branded products to market.

Semi-Solid Dosage Contract Manufacturing Market- Segmentation Analysis:

The Global Semi-Solid Dosage Contract Manufacturing Market is segmented on the basis of Product, Application, Type, Company Size, End User, and Region.

By product, creams remain the most prevalent product type since their formulation offers the greatest degree of variability in terms of active ingredients, indication, release rate, and patient preferences. The well-established processes of mixing, homogenizing, temperature control, and filling allow CDMOs to balance the production of generic, brand, or lifecycle programs while following different production schemes. Meanwhile, gels, lotions, ointments, pastes, and similar formulations remain in demand for topical administration, where the need for skin penetration capacity, occlusivity, specific textures, or targeted action is most acute. The FDA approved the first generic tazarotene lotion in 2025 for the treatment of acne, reflecting the continuous interest in topical drugs. As a result, the ability to navigate cream production with high versatility in formulation remains an advantage for contract manufacturers.

By application, dermatology field remains the primary application as it benefits most from the unique attributes of semi-solid formulations. The variety of vehicles, release mechanisms, absorption rates, and convenience of use enables manufacturers to address the key requirements of indication, individual patient needs, and administration ease. While gynecology and hormone therapy are also interested in topical formulations, they impose more stringent requirements on the choice of vehicle, dosage, absorption mechanisms, and packaging options. In contrast, eye drops, ointments, and similar formulations require higher levels of sterility and control over foreign particles and contaminants, thus limiting the choice of manufacturers. Another illustration of topical drugs' versatility is the FDA approval of Anzupgo cream in 2025 for the treatment of chronic hand eczema. The range of applications that may benefit from semi-solid formulations shapes the outsourcing patterns of manufacturers; the standard approaches used in dermatology call for a higher ability to scale, while niche treatments value sterile production, enhanced analytical support, and regulatory expertise.

Semi-Solid Dosage Contract Manufacturing Market- Geographical Insights

North America remains a key region for semi-solid contract manufacturing due to its well-established pharmaceutical industry, heavy reliance on generic drug production, specialized CDMO networks, and presence of formulation developers and regulators. The region is home to drug sponsors, contract manufacturers, analytical laboratories, and regulatory experts that support the demand for technology transfer and compliant commercial production. According to FDA reports, there were 92 first-time generic approvals in fiscal year 2025, indicating the continuous interest in generic drug programs. Therefore, CDMOs that operate within the region are highly dependent on the local market and regulatory environment. North America is a dominant region for semi-solid contract manufacturers due to the established presence of formulation owners and regulatory approval centers.

Asia-Pacific is an emerging region for semi-solid contract manufacturing due to its production capabilities, formulation expertise, cost-effective process development, and export-oriented manufacturing networks. Notably, India is witnessing an increased role in the global pharmaceutical supply chain, as the local contract manufacturing sector provides end-to-end services for developers and regulators. Recipharm's Bengaluru site, for example, operates four separate facilities that support the development, clinical, and commercial supply chains for semi-solid production. Therefore, the region attracts manufacturers that seek to integrate their technical roles across multiple markets, supported by India's strong formulation expertise. The Asia-Pacific region competes against other regions in semi-solid contract manufacturing on technical services and production capabilities, with a strong emphasis on regulatory compliance and quality control.

Semi-Solid Dosage Contract Manufacturing Market- Competitive Landscape:

Competition in the semi-solid dosage contract manufacturing market is primarily driven by the replicability of formulations, analytical expertise, process validation, and the ability to transition products from development into commercial manufacturing. CDMOs offering unique expertise in rheology, formulation development, high potency, sterile production, packaging, regulatory know-how, and technology transfer capabilities are gaining an edge over others. Recipharm, for instance, reported in 2025 that it produced several hundred products for its customers in the pharma industry and across different dosage forms. Other key players, such as FAREVA, specialize in dosage forms and utilize their extensive networks of manufacturing sites around the globe to meet the needs of pharmaceutical companies. The trend in the contract manufacturing industry indicates that the competitive advantage is gained by offering end-to-end development to commercial platforms, validated processes, regulatory expertise, and reliable batch manufacturing.

Recent Developments:

In May 2025, FAREVA and Zhaoke Ophthalmology announced the opening of a manufacturing cooperation to support pharmaceutical production in China. The joint effort is dedicated to the development of eye care products both locally and with the possibility of outsourcing.

In September 2025, Recipharm launched its new corporate identity to unify the work on the development and manufacturing of generic and branded pharmaceuticals under one brand name. Thus, the company highlights its expertise in the field and commitment to continuous improvement in its services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Lonza Group Ltd.
Lubrizol Life Science
Bora Pharmaceuticals
Cambrex Corporation
Contract Pharmaceuticals Limited
Ascendia Pharmaceuticals
Piramal Pharma Solutions
DPT Laboratories, Ltd.
MedPharm Ltd.
Pierre Fabre Group
Catalent, Inc.
Almac Group
Recipharm AB
Aenova Group
Ajinomoto Bio-Pharma Services
ANI Pharmaceuticals, Inc.
Aurigene Pharmaceutical Services Limited
Douglas Pharmaceuticals Ltd.
Ferndale Pharma Group
Sterling Pharmaceutical Services LLC
Aphena Pharma Solutions Inc.
Fermion Oy
Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

Creams
Pastes
Gels
Lotions
Ointments
Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Gynecology
Dermatology
Ophthalmology
Hormonal therapy
Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Transdermal
Topical
Oral

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY COMPANY SIZE- MARKET ANALYSIS, 2020 - 2033

Medium and Small-Size Companies
Large-Size Companies
Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Cosmeceutical Companies
Pharmaceutical Companies
Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV7278

1. Semi-Solid Dosage Contract Manufacturing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
2.2. Competitive Insights

3. Semi-Solid Dosage Contract Manufacturing Key Market Trends

3.1. Semi-Solid Dosage Contract Manufacturing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Semi-Solid Dosage Contract Manufacturing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Semi-Solid Dosage Contract Manufacturing Market Opportunities
3.4. Semi-Solid Dosage Contract Manufacturing Market Future Trends

4. Semi-Solid Dosage Contract Manufacturing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Semi-Solid Dosage Contract Manufacturing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Semi-Solid Dosage Contract Manufacturing Market Landscape

6.1. Semi-Solid Dosage Contract Manufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Semi-Solid Dosage Contract Manufacturing Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
- 7.1.2. Creams
- 7.1.3. Pastes
- 7.1.4. Gels
- 7.1.5. Lotions
- 7.1.6. Ointments
- 7.1.7. Others

8. Semi-Solid Dosage Contract Manufacturing Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Gynecology
- 8.1.3. Dermatology
- 8.1.4. Ophthalmology
- 8.1.5. Hormonal therapy
- 8.1.6. Others

9. Semi-Solid Dosage Contract Manufacturing Market - By Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 9.1.2. Transdermal
- 9.1.3. Topical
- 9.1.4. Oral

10. Semi-Solid Dosage Contract Manufacturing Market - By Company Size

10.1. Overview
- 10.1.1. Segment Share Analysis, By Company Size, 2025 & 2033 (%)
- 10.1.2. Medium and Small-Size Companies
- 10.1.3. Large-Size Companies
- 10.1.4. Others

11. Semi-Solid Dosage Contract Manufacturing Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Cosmeceutical Companies
- 11.1.3. Pharmaceutical Companies
- 11.1.4. Others

12. Semi-Solid Dosage Contract Manufacturing Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Semi-Solid Dosage Contract Manufacturing Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Lonza Group Ltd.
- 13.2.2. Lubrizol Life Science
- 13.2.3. Bora Pharmaceuticals
- 13.2.4. Cambrex Corporation
- 13.2.5. Contract Pharmaceuticals Limited
- 13.2.6. Ascendia Pharmaceuticals
- 13.2.7. Piramal Pharma Solutions
- 13.2.8. DPT Laboratories, Ltd.
- 13.2.9. MedPharm Ltd.
- 13.2.10. Pierre Fabre Group
- 13.2.11. Catalent, Inc.
- 13.2.12. Almac Group
- 13.2.13. Recipharm AB
- 13.2.14. Aenova Group
- 13.2.15. Ajinomoto Bio-Pharma Services
- 13.2.16. ANI Pharmaceuticals, Inc.
- 13.2.17. Aurigene Pharmaceutical Services Limited
- 13.2.18. Douglas Pharmaceuticals Ltd.
- 13.2.19. Ferndale Pharma Group
- 13.2.20. Sterling Pharmaceutical Services LLC
- 13.2.21. Aphena Pharma Solutions Inc.
- 13.2.22. Fermion Oy
- 13.2.23. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us